Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Fractyl Health (GUTS) EBIT Margin (2023 - 2024)

Fractyl Health (GUTS) has disclosed EBIT Margin for 2 consecutive years, with 840333.33% as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, EBIT Margin fell 65489048.0% year-over-year to 840333.33%, compared with a TTM value of 3291400.0% through Sep 2025, down 320758351.0%, and an annual FY2024 reading of 100570.97%, down 5820763.0% over the prior year.
  • EBIT Margin was 840333.33% for Q4 2024 at Fractyl Health, down from 169957.14% in the prior quarter.
  • Across five years, EBIT Margin topped out at 16493.06% in Q2 2023 and bottomed at 840333.33% in Q4 2024.